PeptidesInfo
Benefits

Sermorelin: Benefits, Uses, and What the Evidence Shows

Sermorelin nudges your body to make its own growth hormone. It was once FDA-approved for children's growth, and is now used off-label for anti-aging and body composition. The direct human evidence is limited but promising. Here's the honest read.

Abstract lattice illustration for the sermorelin research analysis
Contents
  1. What sermorelin is
  2. A drug with an unusual history
  3. What the evidence shows
  4. The part the "anti-aging" pitch leaves out
  5. The bottom line
  6. Where to go next

Key findings

  1. 1Sermorelin is a GHRH peptide - it signals your pituitary to release more of your own growth hormone, rather than injecting growth hormone directly.
  2. 2It was once FDA-approved (as Geref) for children's growth hormone deficiency, then discontinued from the market.
  3. 3It is now used off-label for anti-aging and body composition, mostly via compounding pharmacies.
  4. 4It reliably raises growth hormone and IGF-1; the evidence for real-world benefits like fat loss and lean mass is limited and preliminary.
  5. 5Raising growth hormone is not automatically good - the risk-benefit in healthy adults is not well established.

Evidence level

Preliminary evidence

Sermorelin reliably prompts the body to release more of its own growth hormone. The direct human evidence for anti-aging benefits like better body composition is limited and preliminary, coming largely from small studies of GHRH-family peptides in older adults.

Regulatory status

Withdrawn or discontinued

The branded sermorelin product (Geref) was FDA-approved for pediatric growth hormone deficiency but was later discontinued from the market. Sermorelin is now used off-label, mainly through compounding pharmacies, and is not a currently approved product.

Sermorelin is sold as a gentler, smarter way to raise growth hormone - not by injecting the hormone itself, but by nudging your body to make more of its own. It has a genuinely interesting history: it used to be an FDA-approved children's medicine. Here is what it does, and how much of the "anti-aging" pitch the evidence actually supports.

What sermorelin is

Sermorelin is a GHRH peptide - a copy of the natural signal (growth hormone-releasing hormone) that tells your pituitary gland to release growth hormone.

That is the key difference from taking HGH directly:

  • HGH floods your body with outside growth hormone.
  • Sermorelin asks your own gland to make more - keeping more of the body's natural feedback and control[1].

In theory, that is a more natural, self-limiting approach. In practice, the question is whether it actually delivers the benefits people want.

A drug with an unusual history

Here is a detail most sellers skip: sermorelin was once FDA-approved. The branded version, Geref, was approved for growth hormone deficiency in children - and then discontinued from the market. It was not pulled for safety; the maker simply stopped selling it.

Today, sermorelin is used off-label, mostly through compounding pharmacies, for anti-aging and body composition. So it sits in an unusual spot: a peptide with real clinical history that is no longer sold as an approved product.

What the evidence shows

The clearest finding is the mechanism: sermorelin (and its GHRH-family relatives) reliably increase growth hormone and IGF-1[1]. That part is not in doubt.

For the benefits people actually chase - less fat, more lean mass, better recovery, more energy - the human evidence is limited and preliminary. Small studies of GHRH-family peptides in older adults have shown modest improvements in body composition (a little more lean mass, a little less fat)[1], but these are early results, not large or long trials.

The part the "anti-aging" pitch leaves out

Raising growth hormone is not automatically good. Growth hormone has real effects, and pushing it up in a healthy adult can bring downsides - fluid retention, joint aches, blood-sugar changes. The honest framing is that sermorelin's risk-benefit in healthy people is not well established, which is very different from the "safe, natural anti-aging" story it is often sold with.

The bottom line

Sermorelin is a legitimate peptide with a real mechanism and an unusual regulatory history. It reliably nudges up your own growth hormone. Whether that turns into the fat loss, muscle, and "anti-aging" results it is marketed for is a much weaker claim - the human evidence is preliminary, and more growth hormone is not a free lunch.

Where to go next

Frequently asked questions

What are the benefits of sermorelin?
Sermorelin raises your body's own growth hormone and IGF-1. Small studies of GHRH-family peptides in older adults suggest modest improvements in body composition - a bit more lean mass, a bit less fat - but the direct human evidence is limited, so treat the benefits as preliminary.
Is sermorelin FDA-approved?
Not currently. The branded product (Geref) was FDA-approved for growth hormone deficiency in children, but it was discontinued from the market. Sermorelin is now used off-label, mostly through compounding pharmacies.
Is sermorelin better than HGH?
It works differently. HGH replaces growth hormone directly; sermorelin signals your body to make its own, which keeps more of the natural feedback loop intact. Whether that translates into better real-world results in healthy adults is not well established.
Is sermorelin safe?
It has a long history of clinical use and is generally well tolerated in studies. But raising growth hormone is not automatically good for you, long-term safety in healthy adults is not established, and compounded products are less tightly regulated than an approved drug.

References

Numbered in order of first use. Study type is shown for every source; see our methodology for how we rank evidence.

  1. 1.

    Endocrine and Metabolic Effects of Long-Term Administration of a Growth Hormone-Releasing Hormone-(1-29) Analog in Age-Advanced Men and Women Journal of Clinical Endocrinology & Metabolism, 1997.

    Human studyOlder ("age-advanced") men and women

    Result: Long-term administration of a GHRH-(1-29) analog (the sermorelin family) in older adults increased growth hormone and IGF-1 and was associated with modest improvements in body composition, supporting the mechanism while highlighting that effects were preliminary.

    ↑ back to text

Review status: Editorially reviewed against primary sources. This article was fact-checked against the primary sources listed in the references by our editorial team, and it has not been reviewed by a licensed clinician. It is educational content, not medical advice. Read our editorial policy and methodology. Spotted an error? Tell us.

sermorelingrowth hormoneGHRHanti-agingbody compositionIGF-1

Continue researching

Related analyses, profiles, and research areas

Recommendations are ranked by shared peptides, research areas, evidence level, and topic tags — not by popularity.

Research analysis5 min read

CJC-1295 and Ipamorelin: Growth Hormone Research and Unanswered Risks

The 'CJC/ipa' stack is sold for muscle, fat loss, sleep and anti-aging. The human evidence is a handful of short hormone-level studies, two abandoned development programmes, and no outcome trials — plus a set of risks that have never been studied because the trials were never run.

Benefits3 min read

Ipamorelin Benefits: What the Research Actually Shows

Ipamorelin is sold for muscle, fat loss and anti-aging by raising growth hormone. It does raise GH cleanly in studies - but raising GH is not the same as building muscle or reversing aging. Here is the honest split.

Benefits5 min read

GLP-1 Benefits Beyond Weight Loss: Heart, Kidney, Liver, and Sleep

Semaglutide and tirzepatide have now shown benefits in cardiovascular events, kidney disease, liver disease, heart failure and sleep apnoea — each in its own trial, in its own population. Here is what each one actually demonstrated.

Benefits8 min read

Peptide Benefits: What the Evidence Actually Supports

Peptides are credited with dozens of benefits. Some are proven in large trials, some are modest and real, and some have never been tested in a person. This is every major benefit claim, sorted by how strong the human evidence is.